Search Results - "Munding, J"

Refine Results
  1. 1
  2. 2
  3. 3

    TME quality in rectal cancer surgery by Herzog, T, Belyaev, O, Chromik, A M, Weyhe, D, Mueller, C A, Munding, J, Tannapfel, A, Uhl, W, Seelig, Matthias H

    Published in European journal of medical research (26-07-2010)
    “…The concept of total mesorectal excision has revolutionised rectal cancer surgery. TME reduces the rate of local recurrence and tumour associated mortality…”
    Get full text
    Journal Article
  4. 4

    Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature by Pohl, M, Werner, N, Munding, J, Tannapfel, A, Graeven, U, Nickenig, G, Schmiegel, W, Reinacher-Schick, A

    Published in Zeitschrift fur Gastroenterologie (01-10-2011)
    “…Tumour angiogenesis via vascular endothelial growth factor (VEGF) is essential for promoting tumour progression and is overexpressed in colorectal cancer. The…”
    Get more information
    Journal Article
  5. 5

    Histological classification: evaluation of resection specimens of EMR/ESD--response evaluation after neoadjuvant therapy by Munding, J, Ziebarth, W, Belyaev, O, Uhl, W, Tannapfel, A

    Published in Zentralblatt fur Chirurgie (01-12-2013)
    “…The surveillance of patients with Barrett mucosa in the distal oesophagus leads to an increase of patients diagnosed with early cancer of the oesophagogastric…”
    Get more information
    Journal Article
  6. 6

    Effects of Intra-Arterial Octreotide on Pancreatic Texture: A Randomized Controlled Trial by Belyaev, O., Polle, C., Herzog, T., Munding, J., Chromik, A. M., Meurer, K., Tannapfel, A., Bergmann, U., Müller, C. A., Uhl, W.

    Published in Scandinavian journal of surgery (01-09-2013)
    “…Background and Aims: Octreotide is suggested to harden the pancreas, thus facilitating the construction of a pancreatic anastomosis and lowering the risk of…”
    Get full text
    Journal Article
  7. 7

    Solid pseudopapillary tumors of the pancreas: a case series, comparison of histopathological and clinical data by Munding, J, Sunitsch, S, Belyaev, O, Liffers, S-T, Uhl, W, Tannapfel, A

    Published in Zeitschrift fur Gastroenterologie (01-10-2011)
    “…Solid pseudopapillary neoplasms (SPNs) are rare pancreatic tumors. They occur most frequently in young females and are often diagnosed accidentally. SPNs are…”
    Get more information
    Journal Article
  8. 8

    Pathogenese des sporadischen und hereditären Kolonkarzinoms by Munding, J., Tannapfel, A.

    Published in Der Onkologe (01-12-2009)
    “…Zusammenfassung Bereits vor 20 Jahren wurde die Adenom-Karzinom-Sequenz zur Entstehung kolorektaler Karzinome beschrieben. Heute geht man davon aus, dass es…”
    Get full text
    Journal Article
  9. 9

    Pathological anatomical characteristics of Klatskin tumors. Classification, current molecular biological aspects, prognosis factors by Munding, J, Tannapfel, A

    Published in Chirurg (01-03-2012)
    “…Klatskin tumors are a distinct subgroup of cholangiocarcinomas which are a surgical challenge due to their special localization. Different localizations do not…”
    Get full text
    Journal Article
  10. 10

    Update of the S3 guidelines for pancreatic cancer. What is new for pathologists? by Munding, J, Lüttges, J, Esposito, I, Tannapfel, A

    Published in Der Pathologe (01-09-2014)
    “…The S3 guidelines for pancreatic cancer were revised in 2013. Besides the oncological and palliative therapy modalities and surgical therapy, the guidelines…”
    Get full text
    Journal Article
  11. 11

    Anatomy of the liver. What does the radiologist need to know? by Munding, J, Tannapfel, A

    Published in Radiologe (01-08-2011)
    “…The liver is the largest unpaired parenchymatous organ in the human body and takes part in almost all important metabolic processes. Many patients show…”
    Get full text
    Journal Article
  12. 12

    Anatomisch-pathologische Besonderheiten der Klatskin-Tumoren: Klassifikation, aktuelle molekularbiologische Aspekte, Prognosefaktoren by Munding, J., Tannapfel, A.

    Published in Chirurg (01-03-2012)
    “…Zusammenfassung Es handelt sich bei den Klatskin-Tumoren um eine Subgruppe der Gallengangkarzinome, die aufgrund ihrer besonderen Lokalisation eine…”
    Get full text
    Journal Article
  13. 13

    Pathologie des CUP-Syndroms: Klassische Histologie und molekulare Diagnostik by Munding, J., Tannapfel, A.

    Published in Der Onkologe (2013)
    “…Zuammenfassung Das sog. CUP-Syndrom („carcinoma of unknown primary“) stellt den diagnostizierenden Arzt und den betroffenen Patient vor eine große…”
    Get full text
    Journal Article
  14. 14

    Differenzierte Bewertung der Adenom-Karzinom-Sequenz beim kolorektalen Karzinom: Welche Rolle spielt das serratierte Adenom? by Munding, J., Tannapfel, A.

    Published in Gastroenterologe (01-11-2013)
    “…Zusammenfassung Kolorektale Karzinome gehören zu den häufigsten Tumorerkrankungen weltweit. Um die heute bestehenden Vorsorgemöglichkeiten effektiv zu nutzen,…”
    Get full text
    Journal Article
  15. 15

    Anatomie der Leber: Was muss der Radiologe wissen? by Munding, J., Tannapfel, A.

    Published in Radiologe (2011)
    “…Zusammenfassung Die Leber stellt das größte unpaarige parenchymatöse Organ des menschlichen Körpers dar und ist wesentlich an den zentralen…”
    Get full text
    Journal Article
  16. 16

    R classification and pancreatic ductal adenocarcinoma--R 0 is R 0 by Munding, J, Uhl, W, Tannapfel, A

    Published in Zeitschrift fur Gastroenterologie (01-10-2011)
    “…The ductal adenocarcinoma of the pancreas is characterised by a very poor prognosis due to an early inoperability of the tumours. Even if operated under…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Update der S3-Leitlinie für das Pankreaskarzinom: Was ist neu für Pathologen? by Munding, J., Lüttges, J., Esposito, I., Tannapfel, A.

    Published in Der Pathologe (01-09-2014)
    “…Zusammenfassung Die S3-Pankreaskarzinomleitlinie wurde im letzten Jahr aktualisiert. Neben der internistisch-onkologischen und Palliativtherapie standen die…”
    Get full text
    Journal Article
  20. 20

    Pathologie des ösophagogastralen Adenokarzinoms: Von der Karzinogenese zur molekularen Therapie by Munding, J., Stüken, W., Tannapfel, A.

    Published in Der Onkologe (01-05-2013)
    “…Zusammenfassung Hintergrund Adenokarzinome des ösophagogastralen Übergangs (AEG) und des Magens weisen vergleichbare Vorläuferläsionen und genetische…”
    Get full text
    Journal Article